PCOS Workup
Diagnose PCOS using the Rotterdam criteria—requiring at least two of three features: hyperandrogenism, ovulatory dysfunction, or polycystic ovarian morphology—after systematically excluding other causes of androgen excess through targeted laboratory testing and clinical assessment. 1
Initial Clinical Assessment
History Components
Document the following specific elements:
- Menstrual pattern: Onset and duration of oligomenorrhea or amenorrhea 2
- Androgen excess signs: Timing and progression of hirsutism, acne, or alopecia 2
- Medication review: Screen for exogenous androgen use 2
- Lifestyle factors: Diet, exercise habits, alcohol consumption, smoking status 2
- Family history: Cardiovascular disease, diabetes, and reproductive disorders 2
Physical Examination Findings
Systematically assess for:
- Hyperandrogenism signs: Acne distribution, male-pattern balding, clitoromegaly 1
- Hirsutism: Document body hair distribution patterns 1
- Insulin resistance markers: Acanthosis nigricans on neck, axillae, beneath breasts, or vulva 2, 1
- Body habitus: Calculate BMI and waist-hip ratio 2
- Ovarian enlargement: Pelvic examination findings 2
- Cushing's features: Buffalo hump, moon facies, hypertension, abdominal striae, centripetal fat distribution, easy bruising, proximal myopathy 2
Laboratory Workup
Essential Hormonal Testing
Order these tests to confirm PCOS features and exclude mimicking disorders:
- Testosterone: Total or free testosterone using mass spectrometry (superior specificity over immunoassays) to document hyperandrogenism 1
- TSH: Exclude thyroid disease as cause of menstrual irregularity 2, 1
- Prolactin: Rule out hyperprolactinemia 2, 1
- 17-hydroxyprogesterone: Exclude nonclassic congenital adrenal hyperplasia 1
Metabolic Screening (Required for All PCOS Patients)
These tests assess cardiovascular and diabetes risk regardless of BMI:
- 2-hour oral glucose tolerance test with 75-gram glucose load: Screen for type 2 diabetes and glucose intolerance in all women with PCOS 2, 1
- Fasting lipid profile: Total cholesterol, LDL, HDL, and triglycerides to assess dyslipidemia driven by insulin resistance 2, 1
Additional Testing When Indicated
Consider based on clinical suspicion:
- 24-hour urinary free cortisol or dexamethasone suppression test: When Cushing's syndrome features are present 2
Imaging Assessment
Transvaginal Ultrasound (First-Line)
Use high-frequency transducer (≥8 MHz) to document:
- Follicle count: ≥25 follicles measuring 2-9 mm in diameter in at least one ovary confirms polycystic ovarian morphology 2, 1
- Ovarian volume: >10 mL suggests PCOS 2
- Stromal echogenicity: Increased echogenicity is the most sensitive and specific ultrasound sign, though subjective 2
Alternative Imaging
- Transabdominal ultrasound: Reliable for ovarian volume >10 mL but inadequate for accurate follicle counts due to lower transducer frequency 2
- MRI pelvis: Consider in obese adolescents or when transvaginal ultrasound is unacceptable; provides reproducible ovarian volume assessment 2
Diagnostic Algorithm
Step 1: Confirm at least two Rotterdam criteria are present:
- Clinical or biochemical hyperandrogenism
- Ovulatory dysfunction (oligomenorrhea or amenorrhea)
- Polycystic ovarian morphology on ultrasound 1, 3
Step 2: Exclude alternative diagnoses through targeted testing:
- Thyroid disease (TSH) 1
- Hyperprolactinemia (prolactin) 1
- Nonclassic congenital adrenal hyperplasia (17-hydroxyprogesterone) 1
- Cushing's syndrome (if clinical features present) 2
- Androgen-secreting tumors (if severe/rapid-onset virilization) 2
Step 3: Assess metabolic complications in all diagnosed patients:
Critical Pitfalls to Avoid
- Adolescents: PCOS diagnosis is problematic in this age group; hyperandrogenism must be central to the presentation as irregular cycles are physiologic 3
- Postmenopausal women: No consistent PCOS phenotype exists; diagnosis is unreliable 3
- Acanthosis nigricans: When present, consider associated insulinoma or gastric adenocarcinoma, not just insulin resistance 2
- Normal weight patients: Do not skip metabolic screening—up to 50% of PCOS patients are normal weight but still have metabolic dysfunction 1, 4
- Incidental polycystic ovaries on ultrasound: Polycystic ovarian morphology alone without clinical/biochemical features does not establish PCOS diagnosis 5
Documentation Requirements
When confirming PCOS diagnosis, clearly document:
- Specific phenotype: Which two or three Rotterdam criteria are met 6
- Excluded diagnoses: List alternative causes ruled out 1
- Metabolic risk profile: Baseline glucose tolerance and lipid status 1
- Long-term surveillance plan: Endometrial cancer risk monitoring (obesity, chronic anovulation, hyperinsulinemia) 2, 1